Gene752
FMNL1: formin like 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FMNL1: formin like 1. Genes, record 752. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/752
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O95466 | Formin-like protein 1 | 1,100 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents19
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4641201 A2 | 2025-10-29 | 5499 | O95466 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1592 | O95466 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1592 | O95466 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 5499 | O95466 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 28508 | O95466 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 28508 | O95466 | Espacenet |
| JP 2023058610 A | 2023-04-25 | 28508 | O95466 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 5547 | O95466 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 32736 | O95466 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 135707 | O95466 | Espacenet |
NIH grants361
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FMNL1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA023108 | Cancer Center Support Grant | 3 | 2025 |
| P20GM113132 | The Institute for Biomolecular Targeting | 2 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 2 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 2 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 2 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 2 | 2025 |
| P50CA136393 | Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancer | 2 | 2025 |
| R01AI087644 | Mechanoregulation of cytotoxic lymphocyte function | 2 | 2025 |
Source NIH's project files
Papers370
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Daam-, FMNL-, and mDia-family formins jointly regulate cortical actin dynamics in melanoma cells. | Cell Commun Signal | 2026 | 42827260 | PubTator, text mining | PubMed |
| LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling. | Oncogene | 2026 | 42373804 | PubTator, text mining | PubMed |
| Discovery of tumor antigens in renal cell carcinoma and prospects for clinical application. | Front Immunol | 2026 | 41972142 | PubTator, text mining | PubMed |
| Loss of DIAPH3 accelerates glioma genesis in mice. | Cell Death Dis | 2026 | 41872154 | PubTator, text mining | PubMed |
| Transcriptomic profiling of clear cell renal cell carcinoma reveals age-dependent molecular signatures and clinical stratification patterns. | PLoS One | 2026 | 41805734 | PubTator, text mining | PubMed |
| The Src inhibitor peptide TAT-Cx43266-283 improves survival in an intracranial murine model of lung cancer brain metastasis. | Neurooncol Adv | 2026 | 41756757 | PubTator, text mining | PubMed |
| Region-resolved proteomic map of the human brain: functional interconnections and neurological implications. | Signal Transduct Target Ther | 2026 | 41633974 | PubTator, text mining | PubMed |
| Early feature extraction drives model performance in high-resolution chromatin accessibility prediction. | Genome Res | 2026 | 41526189 | PubTator, text mining | PubMed |
| Nuclear mechanobiology rules immune cells' functions: from differentiation to cell trafficking and pathogen killing. | Nucleus | 2026 | 41495604 | PubTator, text mining | PubMed |
| A Rho GTPase-effector ensemble governs cell migration behavior. | Nat Commun | 2025 | 41173885 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/752
GET https://conductscience.org/api/genes/v1/752/patents